Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255
Open Access
- 1 September 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (9) , 1141-1146
- https://doi.org/10.1023/a:1008395400069
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- CODBLAM IV Chemotherapy for Large Cell LymphomaAmerican Journal of Clinical Oncology, 1997
- Infusional Chemotherapy for Non-Hodgkin's LymphomaCancer Investigation, 1997
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995
- Infusional Chemotherapy (EPOCH) in Patients with Refractory or Relapsed LymphomaAmerican Journal of Clinical Oncology, 1995
- EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1993
- Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: evidence for a schedule-dependent effect favoring infusional administration of chemotherapy.Journal of Clinical Oncology, 1993
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Combination Chemotherapy of Advanced Diffuse Histiocytic Lymphoma with the Six-Drug COP-BLAM RegimenAnnals of Internal Medicine, 1982
- National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCancer, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958